|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3411402 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17703376.8 |
| Date of filing the European patent application | 2017-02-02 | |
| (97) | Date of publication of the European application | 2018-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
| (46) | Date of publication of the claims translation | 2022-01-25 |
| (86) | Number | PCT/EP2017/052202 |
| Date | 2017-02-02 |
| (87) | Number | WO 2017/134134 |
| Date | 2017-08-10 |
| (30) | Number | Date | Country code |
| 201662290831 P | 2016-02-03 | US |
| (72) |
RAUM, Tobias , DE
MUENZ, Markus , DE
BROZY, Johannes , DE
KUFER, Peter , DE
HOFFMANN, Patrick , DE
FRIEDRICH, Matthias , DE
RATTEL, Benno , DE
BOGNER, Pamela , DE
WOLF, Andreas , DE
POMPE, Cornelius , DE
|
| (73) |
Amgen Research (Munich) GmbH ,
Staffelseestrasse 2, 81477 München,
DE
Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | BCMA ir CD3 bispecifinis T ląsteles sužadinantis antikūno konstruktas |
| BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS |
| Payment date | Validity (years) | Amount | |
| 2025-01-22 | 9 | 208.00 EUR |
| 2026-02-02 |